Brad Loncar, Head of Loncar Investments, joins us in studio to spotlight the index behind the Loncar Cancer Immunotherapy ETF (CNCR) and discuss the innovation occurring in cancer treatment.  Nate and Conor also explain why ETFs can be an excellent way to access the biotech space in general.